RocketTickers

Aldeyra Therapeutics Announces Positive Results from Phase 2b

做多
NASDAQ:ALDX   Aldeyra Therapeutics, Inc.
ALDX : Aldeyra Therapeutics, Inc.
2018-09-26 07:00:00
Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trial
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。